Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

May 31, 2021

5250_rns_2021-05-31_d538f5a6-243f-4669-8179-b3c45d9ea402.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

FORM 8.3 – WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 28 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,862,052 1.44% 228,687 0.18%
(2) Derivatives (other than options):
72,359 0.06% 94,581 0.07%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,940,511 1.50% 329,368 0.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 261.7600 USD
Purchase 10 262.4300 USD
Purchase 34 262.9700 USD
Purchase 41 262.2500 USD
Purchase 100 261.3700 USD
Purchase 100 261.9300 USD
Purchase 165 262.1263 USD
Purchase 200 261.6200 USD
Purchase 200 261.7875 USD
Purchase 400 261.3075 USD
Purchase 700 261.6742 USD
Purchase 779 261.4778 USD
Purchase 900 261.4475 USD
Purchase 1,307 261.8607 USD
Purchase 1,327 261.8587 USD
Purchase 1,827 261.5490 USD
Purchase 2,169 261.8225 USD
Purchase 2,250 261.3491 USD
Purchase 5,712 261.4582 USD
Purchase 5,735 261.3600 USD
Purchase 10,000 261.7900 USD
Purchase 11,708 261.3623 USD
Purchase 11,840 261.3861 USD
Sale 37 261.5400 USD
Sale 78 261.5433 USD
Sale 100 261.9700 USD
Sale 100 262.3700 USD
Sale 100 261.5900 USD
Sale 252 261.6541 USD
Sale 304 261.5180 USD
Sale 403 261.6953 USD
Sale 842 261.6633 USD
Sale 855 261.6907 USD
Sale 924 261.9300 USD
Sale 1,100 261.2218 USD
Sale 1,500 261.4372 USD
Sale 1,665 261.4983 USD
Sale 2,005 261.5125 USD
Sale 2,250 261.3491 USD
Sale 2,995 261.7200 USD
Sale 5,697 261.3600 USD
Sale 6,976 261.5315 USD
Sale 7,681 261.5425 USD
Sale 10,000 261.7900 USD
Sale 11,746 261.3623 USD
Sale 11,827 261.7527 USD
Sale 12,519 261.4309 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 31 May 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210531005193/en/

BARCLAYS PLC